Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Folate-PEG-folate-graft-polyethylenimine-based gene delivery.

J M Benns1, A Maheshwari, D Y Furgeson

  • 1Center for Controlled Chemical Delivery, Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, 30 South 2000 East, RM 201, Salt Lake City, UT 84112-5820, USA.

Journal of Drug Targeting
|November 8, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction Note: An effective PO-RSNN and FZCIS based diabetes prediction and stroke analysis in the metaverse environment.

Scientific reports·2026
Same author

Pan-Asia adapted ESMO Clinical Practice Guideline for the management of patients with newly diagnosed and relapsed epithelial ovarian cancer.

ESMO open·2025
Same author

An effective PO-RSNN and FZCIS based diabetes prediction and stroke analysis in the metaverse environment.

Scientific reports·2025
Same author

A novel network lifetime maximization technique in WSN using energy efficient algorithms.

Scientific reports·2025
Same author

Publisher Correction: Sustainable sentiment analysis on E-commerce platforms using a weighted parallel hybrid deep learning approach for smart cities applications.

Scientific reports·2024
Same author

Sustainable sentiment analysis on E-commerce platforms using a weighted parallel hybrid deep learning approach for smart cities applications.

Scientific reports·2024
Same journal

Galactosylated chitosan-functionalized liposome for targeted delivery of <i>Coreopsis tinctoria</i> flavonoids: Protective effect in acute liver injury.

Journal of drug targeting·2026
Same journal

Tubulin as a well-established yet underexploited target: new opportunities for drugs repurposing?

Journal of drug targeting·2026
Same journal

Physcion-loaded, folic acid-conjugated DSPE-PEG liposomes for targeted therapy of ulcerative colitis.

Journal of drug targeting·2026
Same journal

Enzyme-responsive 2-dimensional nanomaterials for targeted breast cancer treatment.

Journal of drug targeting·2026
Same journal

Integrating antibody-drug conjugates, multispecific antibodies, targeted protein degradation and nanomedicine in precision oncology.

Journal of drug targeting·2026
Same journal

Nanomaterials for subcellular organelle targeting: unlocking new avenues for enhanced therapeutic effectiveness.

Journal of drug targeting·2026
See all related articles

This study developed folate-polyethylene glycol-folate-grafted-polyethylenimine (FPF-g-PEI) for gene delivery. The novel FPF-g-PEI demonstrated superior transfection efficiency and lower toxicity in cancer cells compared to unmodified polyethylenimine (PEI).

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Gene Delivery Systems

Background:

  • Polyethylenimine (PEI) is a common gene delivery vector but suffers from high toxicity.
  • Folic acid receptor-mediated targeting can enhance gene delivery specificity to cancer cells.
  • Functionalized PEI carriers are needed to improve safety and efficacy.

Purpose of the Study:

  • To synthesize and characterize folate-polyethylene glycol-folate-grafted-polyethylenimine (FPF-g-PEI) as a novel gene delivery vector.
  • To evaluate the transfection efficiency and cytotoxicity of FPF-g-PEI in cancer cells and normal cells.
  • To assess the therapeutic potential of FPF-g-PEI for gene expression.

Main Methods:

  • FPF-g-PEI synthesis and characterization (graft ratio, molecular weight, pH profile).

Related Experiment Videos

  • Plasmid DNA condensation and polyplex characterization (AFM, DLLS).
  • In vitro transfection efficiency assays in smooth muscle cells (SMC) and CT-26 colon adenocarcinoma cells.
  • Cytotoxicity assessment using MTT assay.
  • Gene expression analysis (protein and mRNA) using ELISA and RT-PCR.

    • Main Results:

    • FPF-g-PEI was successfully synthesized with 2.3 folate-PEG-folate grafts per PEI molecule, average MW ~33,500.
    • FPF-g-PEI and PEI formed polyplexes ~150 nm in diameter, suitable for gene delivery.
    • FPF-g-PEI exhibited significantly higher transfection efficiency and lower cytotoxicity in CT-26 cancer cells compared to PEI.
    • No folate-specific targeting was observed in smooth muscle cells; PEI showed higher efficiency.

    Conclusions:

    • FPF-g-PEI represents a promising, less toxic gene delivery vector for cancer therapy.
    • Folate conjugation enhances gene delivery to cancer cells, but specificity in normal cells requires further investigation.
    • The developed FPF-g-PEI carrier holds potential for therapeutic gene expression applications.